Better Decision-Making for Better Outcomes: a Call to Action on Harnessing the Power of Real-World Evidence
Recent years have seen growing recognition of the role that data can play in enabling not only better health system performance, but also better health experiences and outcomes for patients – "outcomes that matter". Real-world data (RWD), in particular, (i.e. routinely collected data relating to patient health status or the delivery of health care from... Read More »Better Decision-Making for Better Outcomes: a Call to Action on Harnessing the Power of Real-World Evidence
Join our CEO Antonella Cardone at the expert roundtable hosted by MEP Stelios Kympouropoulos at the European Parliament and discuss how real-world data can be used to better the outcomes of influenza, rare diseases and cancer. For more information and registration: CLICK HERE
In the 2022 State of the European Union address, European Commission President von den Leyen announced a new European Mental Health Strategy. As a result of this announcement, the European Commission has begun to develop a programme of work. The preliminary strategy, including draft work streams have been published, and a call for response and... Read More »Incontinence and Mental Health. Call for Evidence on a Comprehensive Approach to Mental Health
In order to support the development or strengthening the cooperation among all relevant stakeholders and better understand the role that patients can play in the process, Pancreatic Cancer Europe and Cancer Patients Europe are organising a webinar to exchange views on how best to enhance the cooperation on the HTA process.
On the 17th of November 2022, CPE launched the results of the first European-wide patient survey in genomic testing in breast cancer. 4 out of 5 breast cancer patients eligible for genomic testing are not told it is available to them. The survey was completed by a total of 1,383 respondents from five countries (France,... Read More »myC: first European-wide patient survey in genomic testing in breast cancer